C
Ceptur Therapeutics
About Ceptur Therapeutics
Cepturtx.com is a digital platform that specializes in providing online streaming services. The company primarily focuses on offering a wide range of series and movies, catering to a diverse audience with varying entertainment preferences. The content is accessible via the internet, making it convenient for users to watch their favorite shows and movies anytime, anywhere.
The business operates in the online entertainment market, serving clients who are avid consumers of digital content. The platform is designed to be user-friendly, requiring only a stable internet connection, preferably 4G or higher, and a device such as a mobile phone or a computer.
Cepturtx.com's business model is centered around providing a vast library of digital content that can be accessed through its website. While the specifics of how the company generates revenue are not explicitly stated, businesses in this sector typically monetize through advertisements, subscription fees, or a combination of both.
The company prides itself on its quality service, ensuring that users have a seamless and enjoyable viewing experience. It also regularly updates its content, ensuring that users always have something new to watch.
In summary, Cepturtx.com is a digital platform that provides a wide range of series and movies for online streaming. It operates in the online entertainment market, serving clients who consume digital content. The company generates revenue through advertisements, subscription fees, or both.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AOther financing | Jan 2022 | $75M | $300M | Bristol-Myers Squibb · Janus Henderson Investors · LifeSci Venture Partners · Qiming Venture Partners USA | ↗ |
| EARLY VCOther financing | Aug 2020 | $6.2M | $25M | Affinity Asset Advisors | — |
Growth signals
Latest recorded traffic for Ceptur Therapeutics is 260 monthly website visits, down 52.7% over the last three months. Ceptur Therapeutics's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Ceptur Therapeutics in the Philadelphia ecosystem
The Ceptur Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
US Department of Health and Human Services
Series A9 investors entered at this stage
Affinity Asset Advisors
venBio Partners
Qiming Venture Partners
Bristol-Myers SquibbJanus Henderson Investors
LifeSci Venture Partners
Qiming Venture Partners USA
Boxer Capital- PFPerceptive Xontogeny Venture Fund
Other known investors1 additional known investor
Rutgers university
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Ceptur Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Ceptur Therapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








